中文

1

2

3





About WEPON

WEPON GROUP

Pharmaceutical Holdings

API Division

Company profile

Detail

Brand advantage

Top 100 Chinese National Pharmaceutical Brand Enterprises,The Most Growing Enterprise in China's Pharmaceutical Industry,Top 100 Chinese patent medicine companies

R&D advantages

National academician expert workstation, provincial enterprise research institute, provincial enterprise technology center

Product advantages

Form a product pattern of "features of natural botanical medicines, mainly cardiovascular and cerebrovascular medicines and nervous system medicines, supplemented by medicines in respiratory system and other fields", give full play to the advantages of "raw medicines + preparations", and pursue a two-pronged approach

Scale advantage

Complete modern factory facilities; have a stable supplier system;

News

More

The public service platform project for the industrialization of innovative achievements in the field of medical equipment settled in the China-Africa International Pharmaceutical Industry Cooperation Park

2022

03-14

The public service platform project for the industrialization of innovative achievements in the field of medical equipment settled in the China-Africa International Pharmaceutical Industry Cooperation Park

On March 26, the launching meeting of the Ministry of Industry and Information Technology's "2020 Industrial Technology Basic Public Service Platform Project - Industrialization Public Service Platform for Innovative Achievements in the Field of Medical Equipment" was held in Taizhou. You Shumin, Deputy Director of Industrial Development Promotion of the Ministry of Industry and Information Technology, Jin Xin, Researcher of Zhejiang Provincial Department of Economy and Information Technology, and Chen Tingchen, Deputy Mayor of Taizhou Municipal People's Government attended the meeting and delivered speeches. Representatives of project cooperation units such as Chairman of Wanbangde Medical Technology Co., Ltd. attended the meeting. the meeting.

The 2017 National Medical Device Supervision and Management Work Conference opened in Beijing

2022

03-14

The 2017 National Medical Device Supervision and Management Work Conference opened in Beijing

According to the news from China Pharmaceutical News, on February 16, the 2017 National Medical Device Supervision and Management Work Conference opened in Beijing, which not only summarized the medical device supervision work in 2016, but also deployed the 2017 medical device supervision tasks.

45% of medical device registration items in Zhejiang Food and Drug Administration implement the new "Internet +" approval model

2022

03-14

45% of medical device registration items in Zhejiang Food and Drug Administration implement the new "Internet +" approval model

China Quality News Network News learned from the official website of the State Food and Drug Administration that in accordance with the Zhejiang Provincial Government's deepening of the construction of "four lists and one network" and the reform and deployment of the "delegation, regulation and service" approval system, the first batch of five "license online application, express delivery" "Da" approval items were officially launched on May 20, 2016, two of which are medical device registration items. By the end of the year, 617 items of "change of registration items of Class II medical devices" and 256 items of "medical device clinical trial management and filing" had been handled, accounting for 45% of all medical device registration items of the bureau during the same period.

The development of global 3D printing medical devices will usher in a "blowout"

2022

03-14

The development of global 3D printing medical devices will usher in a "blowout"

With the increasing application of 3D printing in the medical industry, tremendous changes are taking place in the global medical industry. At the same time, the announcements issued by two well-known market research companies in the world believe that the development of the 3D printing medical device market will usher in a "blowout". The development of medicine has never been inseparable from innovation, and innovation in medicine comes from the needs of patients. Although the products that can be printed by 3D bioprinting technology have not yet developed to the extent that they can replace human organs, people see great promise in this rapidly developing technology. The pain point of medical device manufacturers is that they want to experiment with product performance and service life as soon as possible, because medical equipment has very high requirements.